The significance of ARID1B gene expression in determining the overall survival (OS), disease-free survival (DFS), and disease-specific survival (DSS) of COAD patients were assessed, and a low level of ARID1B expression was associated with poor prognosis in all three survival analysis datasets (Figures 1C–E). The gene discussed is ARID1B; the disease is colon adenocarcinoma.